Clinical Trial Update: Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC) [Phase 2]

View source ↗

Summary

Phase 2 multicenter international trial evaluating Ialuril for prevention of radio-induced cystitis in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ialuril

Snippet

Sponsor: Study Group for Urogenital Diseases, Italy | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED